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Abstract 
Background: Neuroscience and neurotechnology are transforming stroke rehabilitation. Robotic devices, in addition 
to telerehabilitation, are increasingly being used to train the upper limbs after stroke, and their use at home allows 
us to extend institutional rehabilitation by increasing and prolonging therapy. The aim of this study is to assess the 
usability of the MERLIN robotic system based on serious games for upper limb rehabilitation in people with stroke in 
the home environment.
Methods: 9 participants with a stroke in three different stages of recovery (subacute, short‑term chronic and long‑
term chronic) with impaired arm/hand function, were recruited to use the MERLIN system for 3 weeks: 1 week training 
at the Maimonides Biomedical Research Institute of Cordoba (IMIBIC), and 2 weeks at the patients’ homes. To evaluate 
usability, the System Usability Scale (SUS), Adapted Intrinsic Motivation Inventory (IMI), Quebec User Evaluation of 
Satisfaction with assistive Technology (QUEST), and the ArmAssist Usability Assessment Questionnaire were used in 
the post‑intervention. Clinical outcomes for upper limb motor function were assessed pre‑ and post‑intervention.
Results: 9 patients participated in and completed the study. The usability assessment reported a high level of satis‑
faction: mean SUS score 71.94 % (SD = 16.38), mean QUEST scale 3.81 (SD = 0.38), and mean Adapted IMI score 6.12 
(SD = 1.36). The results of the ArmAssist Questionnaire showed an average of 6 out of 7, which indicates that MERLIN 
is extremely intuitive, easy to learn and easy to use. Regarding clinical assessment, the Fugl‑Meyer scores showed 
moderate improvements from pre‑ to post‑intervention in the total score of motor function (p = 0.002). There were 
no significant changes in the Modified Ashworth scale outcomes (p = 0.169).
Conclusions: This usability study indicates that home‑based rehabilitation for upper limbs with the MERLIN system is 
safe, useful, feasible and motivating. Telerehabilitation constitutes a major step forward in the use of intensive rehabili‑
tation at home.
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Background
Strokes are among the leading causes of death, physical 
disability and economic burden worldwide [1, 2]. The 
prevalence of people living with the effects of stroke has 
increased over the last few years, thus creating a higher 
demand for rehabilitation services [3]. The paralysis of 
the upper limbs is a common impairment after strokes, 
and only 10–20% of patients recover completely [4, 5]: 
for these patients, the main aim of arm rehabilitation is 
to recover lost functions [6]. Nowadays, the key aspects 
to make rehabilitation effective for people with stroke are 
considered to be intensity, repetition and using suitably 
challenging and function-oriented activities [7–9]. How-
ever, the increase in the number of people affected and 
the current limitation of health resources make it very 
difficult to provide services using a traditional approach.
Continuous advances in neuroscience and neurotech-
nology are transforming stroke rehabilitation [10]. At a 
time when the rehabilitation services resources are una-
ble to meet the demand, robot-assisted rehabilitation and 
home-based telerehabilitation are gaining greater accept-
ance [11]. Robot-based neurorehabilitation systems pro-
vide a solution to increase the number of movements, 
involve safe, intensive rehabilitation exercises [12, 13] and 
have the advantage that the precise movements of the 
robot are able to measure the patients’ movements objec-
tively [14, 15]. On the other hand, home-based telereha-
bilitation allows us to extend institutional rehabilitation 
by increasing and prolonging the therapy [16]. What is 
more, the combination of game-based telerehabilitation 
and robotic systems creates a motivating, engaging envi-
ronment for patients [17]. The enjoyment patients derive 
from playing these so called ‘serious games’, designed spe-
cifically for the rehabilitation tasks, can greatly increase 
the quality and quantity of the therapy delivered [18].
MERLIN is a robotic system based on serious games 
for the upper limb tele rehabilitation in patients with a 
stroke. It is presented as an affordable and easy to use 
solution to allow the patient to carry out an intensive 
rehabilitation at home, with a continuous remote moni-
toring and communication with the therapist. The sys-
tem is composed of an upper-limb rehabilitation robot 
and a software platform which guides and measures the 
patient’s movements and allows physicians to custom-
ize the therapeutic plan and to monitor the patients’ 
evolution.
The purpose of this manuscript is to present the usa-
bility validation of MERLIN system. In this study, we 
evaluate the ease to use, consistency and acceptance of 
the system have been evaluated. The research carried 
out also aims to demonstrate the feasibility of including 




In order to detect most problems of usability which can 
affect a product, Jakob Nielsen’s theory [19] regarding the 
sufficient number of users to evaluate a system is widely 
accepted. According to Nielsen, between three and five 
users can identify 85% of the most relevant usability 
problems. In this case, due to the heterogeneity of the 
study population, it was decided to recruit 12 patients 
at different stages of post-stroke upper limb recovery, in 
order to test as many system features as possible.
 Participants were recruited at the Reina Sof ía Univer-
sity Hospital in Cordoba, Spain. The participants were 
divided in three different groups, depending on their 
stage of recovery: subacute (2–6 months of recovery of 
stroke), short-term chronic (6–12 months) and long-term 
chronic (over 12 months). Four patients were recruited 
from each stage. The inclusion criteria to participate in 
the study were: subjects over 18 with upper limb hemi-
paresis after stroke, unilateral paresis and cognitive abil-
ity to understand, accept and actively participate in the 
usability study. Having Wi-Fi at home and a table meas-
uring 110 × 68 cm on which the MERLIN system can be 
set up was considered also a requirement to participate 
in the study. Patients who presented bilateral motor defi-
cit, severe spasticity, psychiatric illness, and/or cognitive 
impairment were excluded.
 All the subjects were duly informed about the study 
and all of them gave their written consent before the first 
session.
Study design
This interventional study is an open label trial with a sin-
gle group and a longitudinal design. Each patient used 
the MERLIN system for 3 weeks: 1 week training at the 
IMIBIC (Maimonides Biomedical Research Institute in 
Córdoba, Spain) with the supervision of a physiothera-
pist, 1 week at the patient’s home with similar supervi-
sion and 1 week at patient’s home on their own with 
remote support and supervision of a physiotherapist to 
organize the rehabilitation sessions.
Keywords: Stroke, Neurological rehabilitation, Upper extremity, Telerehabilitation, Serious games, Home training, 
Robot
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Arm and hand functions were evaluated at baseline (on 
day 1 before starting the training), and on the last day. 
The usability of the system and the participants’ motiva-
tion was evaluated on the last day using different vali-
dated scales, as explained below.
MERLIN unactuated robotic telerehabilitation system
The MERLIN system has been developed to bring neu-
rorehabilitation to the post-stroke patients’ homes with 
the aim of providing daily, intensive, motivating and 
patient-tailored rehabilitation, with the indirect super-
vision of the therapist [20]. The system is composed of 
ArmAssist (AA), a cost-effective robotic system based on 
serious games developed by TECNALIA, and the Antari 
Home Care platform [21] to supervise, organize and 
customize the patients’ daily training remotely, which 
has been developed by GMV [22]. The AA system is a 
modular solution which includes an affordable, portable 
robotic device for a complete upper limb rehabilitation, 
and a software platform based on serious games to moti-
vate the patients and assess their training [18].
In the MERLIN system, the non-actuated version of 
the AA robotic device has been used to ensure a safe 
use in the home environment when continuous supervi-
sion is not feasible. The AA device includes several sen-
sors to measure the patient’s active self-directed active 
movements during the games, which are performed 
on a normal table to control the games (see Fig. 1). The 
device can be easily fastened on the forearm, and allows 
natural movements with low resistance. The posi-
tion and orientation of the robot are calculated using 
the information from the camera, which reads the QR 
codes on the mat below, and the encoders included on 
the wheels. Wrist angle, hand grasping force and verti-
cal arm force are calculated by a potentiometer, and two 
Force Sensing Resistors (FSR) and a load cell are included 
on the hand module and arm support, respectively. The 
key movements that can be measured are: three types of 
movements over the table, horizontal shoulder abduc-
tion-adduction, flexion–extension in the elbow (verti-
cal force), wrist prono-supination movements and hand 
opening and closing [23]. This version of the system is 
aimed at patients who can actively carry out the move-
ments and is thus more appropriate for patients who 
have mild or moderate motor impairment according to 
the Fugl-Meyer scale, who are more suited to continu-
ing the therapy at home. The movements are used to 
interact with the implemented serious games on the 
software, which are divided into different levels depend-
ing on the patients’ stage of recovery and cognitive capa-
bilities. The games include assessment and training [24] 
and they were co-designed by patients and physiothera-
pists [25]. 7 training games are available, such as choos-
ing letters to make a word, discovering pairs, solitaire or 
doing a puzzle, for example. Additionally, the option of 
using some online games is also available. This option is 
recommended for patients with good movement control 
and cognitive capabilities. The games can be configured 
for only some movements or a combination of different 
ones. The exercises involve extending the user’s range 
of exercises beyond their normal threshold, which has 
been previously set by the assessment games, and can be 
modified when necessary, i.e. when motor improvement 
is detected by the physiotherapist. The games have been 
adapted to for the target group taking into account any 
possible cognitive or visual problems [26].
With the MERLIN system, the patients can access the 
daily therapy previously organized by the therapist, as 
well as viewing a summary of the results obtained during 
therapy (see Fig.  2). It also features a messaging tool to 
communicate with the therapist, similar to mailing.
The AA system has been previously tested in a clinical 
setting by therapists and patients with positive results of 
acceptance [11] and effectiveness, with improvements in 
the patients’ motor function after use [24]. Previous stud-
ies have also demonstrated that the therapy using serious 
games and the AA system is enjoyable and motivating 
because the patients feel more engaged [27]. In the pre-
sent study, the system was adapted for home use using 
the non-actuated version of the robot for greater safety. 
With this aim, the software was programmed to work on 
a tablet to make the system more compact and adaptable 
to the home-setting and package was designed to trans-
port the system, and the mat was adapted to make the 
system easy to transport and store (see Fig. 3).
As previously explained, the Antari HomeCare plat-
form has also been integrated into the MERLIN system. 
This telecare platform designed for managing patients’ Fig. 1 AA system
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treatments and online follow-up, was adapted for remote 
customizing of rehabilitation therapies. The therapist 
used the online platform to plan each patient’s therapy 
and selected the games to be used, the movements to 
train, the number of days to be repeated and the length 
of each game. Monitoring the patient’s evolution and 
therapy (duration of training, frequency, points obtained, 
etc.) was performed online using this software (see 
Fig. 2). The messaging tool was accessible via the Antari 
HomeCare system.
The aim of this usability study was to evaluate the users’ 
acceptance of the new features and remote monitoring 
carried out by the therapist, instead of the face-to-face 
monitoring usually performed in previous evaluations 
of AA [11, 24, 27]. The system safety when patients work 
independently at home was also evaluated, and this feed-
back on usability, acceptance, motivation and safety is an 
important input for demonstrating how easy the system 
is to learn and use.
Intervention sessions
Rehabilitation therapy included 11 sessions using the 
MERLIN system performed over a period of 3 weeks. The 
first week was used as training to teach users and caregiv-
ers how to use the system correctly, as well as for getting 
used to the rehabilitation system, robot movements and 
protocol times. The training sessions were organized 
every day for 1 h at the IMIBIC facilities (see Fig.  4a). 
Special emphasis was placed on the correct positioning 
of the arm and shoulder for rehabilitation.  In addition, 
each participant received a copy of the user’s manual, 
which also included a telephone number to contact in 
case of any technical or clinical problems.  The thera-
pist installed the system at the participant’s home at the 
beginning of the second week, adjusted the chair height 
and explained to the patient the correct back and shoul-
der positions for doing the training as well as the most 
comfortable arm position for rehabilitation when super-
vision was not available (see Fig. 4b). 3 sessions of 30 min 
were held on alternate days. During this week, the patient 
carried out the therapy assigned for each day with the 
supervision of the therapist. The third week followed the 
same timetable, except that the participants were trained 
to use the system at home completely autonomously. The 
therapist used the tele-care platform daily to follow up 
remotely the participants’ progress and their use of the 
system, as well as for organizing the following sessions.
The training movements and games used for this pur-
pose were selected by the therapist, who decided on the 
intensity level and movements to train in the therapy 
according to the patient’s evolution or cognitive condi-
tions. The therapist organized the rehabilitation ses-
sions beforehand, using the tele-care platform designed 
for this purpose. Prior to commencing therapy, patients 
were requested to perform a calibration process to set 
up the threshold according to their range of motion. This 
Fig. 2 Adaptations made to the system for home use. a Adaptation of mat. b Package
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Fig. 3 MERLIN system. a Results of the therapy shown on the therapist’s panel. b Evolution of the therapy shown on the patient’s panel
Page 6 of 16Guillén‑Climent et al. J NeuroEngineering Rehabil           (2021) 18:41 
allowed the participants to set the level of challenge in 
the exercises at their maximum capacity. After that, while 
using the system, the range of motion for each game and 
patient was controlled by the system itself.
Assessment
The study data were collected and managed using RED-
Cap [28] electronic tool hosted at FIBICO (Foundation 
for Biomedical Research in Córdoba, Spain) [29]. RED-
Cap (Research Electronic Data Capture) is a secure, 
web-based software platform designed to support data 
capture for research studies, providing (1) an intuitive 
interface for validated data capture; (2) audit trails for 
tracking data manipulation and export procedures; (3) 
automated export procedures for seamless data down-
loads to common statistical packages; and (4) procedures 
for data integration and interoperability with external 
sources [30, 31]. REDCap is HIPAA (Health Insurance 
Portability and Accountability Act) [32] and 21 CFR Part 
11 [33] compliant, which means that it meets the mini-
mum level of security for data in clinical investigations. 
However, no personal data were recorded on REDCap, in 
compliance with the European General Data Protection 
Regulation (GDPR) [34], as the participants were Euro-
pean citizens.
Primary outcomes measurements. Usability and acceptance 
data
The feasibility of use of the system and motivation were 
evaluated by the patients using semi-structured inter-
views and different usability questionnaires with Likert 
scales during the clinical trials, which lasted for 3 weeks. 
The validated scales used were: the System Usability Scale 
(SUS) [35], the Adapted Intrinsic Motivation Inventory 
(IMI adapted) [36], the Quebec User Evaluation of Satis-
faction with assistive Technology (QUEST) [37], and the 
AA Usability Assessment Questionnaire [18].
The SUS scale was used to evaluate the usability of the 
system. The scores ranged from 0 to 100%, where a higher 
score means better usability, with a threshold of 68%.
The IMI scale is a multidimensional measurement 
method designed to assess participants’ subjective expe-
rience related to a given activity. The full version of the 
questionnaire includes 45  items and 7 subscales. Each 
item is used to rate the statement on a scale ranging 
from 1 ‘strongly agree’ to 7 ‘strongly disagree’ [36, 37]. 
In accordance with the self-determination theory, this 
scale allows the researcher to decide which items to use 
in order to create a shorter version of the questionnaire 
[36]. The version used in the current study consisted of 
twenty items divided into six subscales: interest/enjoy-
ment, perceived competence, effort, pressure/tension, 
perceived choice and value/usefulness. The version used 
can be found in the complementary documentation (see 
Additional file 1) and is very similar to the IMI question-
naires used in other usability studies with robotic devices 
[38, 39].
The purpose of QUEST is to evaluate the patient’s sat-
isfaction with the device and with the services they have 
used. It consists of 12 questions: 8 related to the device 
and 4 related to the services, which must be rated on a 
Likert scale from 1 ‘Not satisfied at all’ to 5 ‘Very satisfied’. 
The AA Usability Assessment Questionnaire consists of 
a 17-item survey and was specifically designed for the 
AA device used in MERLIN system. The questions are 
rated by patients and therapists from 1 ‘strongly agree’ to 
7 ‘strongly disagree’ to evaluate the satisfaction with the 
system and the therapy. It also includes three open-ended 
Fig. 4 Usability of study pictures. a Session at IMIBIC facilities. b Session in a home environment
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questions about the participant’s subjective opinion, such 
as the aspects liked most, any negative aspects identified, 
and any proposals for improving the system.
In addition, two short questions were added to ask the 
participants about their willingness to pay for the MER-
LIN system as therapy.
Secondary outcome measurements. Clinical information
With the aim of quantifying general arm function and 
any effects the system has on it, clinical standardized 
scales were used, before the patients started with the 
therapy using MERLIN and after finishing the clinical 
trial. The Fugl Meyer Upper Extremity Assessment Scale 
(Fugl-Meyer) [40] and the Modified Ashworth Scale 
(MAS) [41] were used to evaluate the patients’ clinical 
condition before their enrolment in the study to confirm 
their participation according to the inclusion criteria. The 
same scales were repeated at the end of the therapy using 
MERLIN to confirm the safety of the system and that no 
negative effects had been caused in the patients such as 
reduction of arm function. Fugl-Meyer and MAS could 
also be used to measure the effectiveness of the system, 
although only small improvements were expected due to 
the short duration of the intervention, in which only lim-
ited clinical evidence could be obtained.
The Fugl-Meyer is an index to assess the sensorimo-
tor impairment in individuals. The MAS measures mus-
cle tone during passive soft tissue stretching by rotating 
a joint and estimating the resistance, and it is used as a 
simple measure of spasticity.
Statistical analysis
The statistical outcomes were analysed using IBM SPSS 
Statistics© [42] software for Windows© Operating Sys-
tem. Descriptive summary statistics (mean with standard 
deviation, SD) was used to process the quantitative data 
provided by the Likert-scale items in SUS, QUEST and 
Adapted IMI. The qualitative data obtained in the open-
ended questions were analysed using thematic analysis.
For the clinical assessment, a one-tailed paired t-test 
with a significance level of p < 0.05 was used to compare 




This clinical study was planned to start in Septem-
ber 2019 and finish in June 2020. During the study, the 
COVID-19 global pandemic broke out, which had a 
significant impact in the study. It was foreseen that 12 
patients with a post-stroke hemiparesis would participate 
in the research, but only 9 of these completed the inter-
vention study. 3 patients dropped out of the study after 
the recruitment period due to the pandemic. A special 
effort was made to recruit additional participants to com-
plete the study, but no patients were willing to partici-
pate in the study during the research period. The patients 
with a post-stroke upper limb impairment included in 
this research usually had a comorbidity such as hyper-
tension, mellitus diabetes, atherosclerosis, heart disease, 
etc. which includes this population in the risk group for 
COVID-19. We were fully aware of this situation, as well 
as the mobility restrictions imposed by the government, 
and because of fear of infection, it was not possible to 
include additional participants at the end of the study. 
However, it was considered that the results are also reli-
able with 9 patients, as was previously explained.
66.7% of the participants were men and 33.3% women. 
Their age range was between 41 and 89, with an average 
of 63.9. 66.7% had left hemiparesis and 33.3% right.
In addition to the therapy received with the MERLIN 
system during the usability study, 88.9% of the patients 
also received other Occupational Therapy or Physiother-
apy sessions (public or private). The characteristics of the 
nine participants are shown in Table 1.
The participants were also asked at the end of each ses-
sion about any adverse effects that may have happened 
during the clinical trial: no relevant adverse effects were 
reported. The participants reported only two drawbacks 
that have been previously foreseen in the user’s manual: 
(1) chafing on the skin due to contact with the robot’s 
protruding elements; and (2) mild shoulder fatigue at the 
end of the session. To avoid any chafing, strips of foam 
were provided to attach to any parts of the robot that 
could cause the problem. This solution should be cus-
tomized to the participant’s arm/hand size. As regards 
shoulder fatigue, the timing of the sessions was adjusted 
to 20–30 min for all the participants with the aim of 
avoiding this adverse side effect.
Usability and acceptance of results
The quantitative data obtained using SUS, QUEST and 
IMI questionnaires is summarized in Figures below, 
which show the results of user acceptance and experi-
ence. The usability perception has been rated with a 
mean score of 71.94 % (SD = 16.38) on the SUS scale (see 
Fig. 5), which means that the system usability is consid-
ered “Good”, according to the research by Bangor et  al. 
[43]
According to the IMI (see Fig.  6b), the participants 
considered the intervention useful (6.06 ± 1.93), con-
sidered themselves competent (5.67 ± 1.79), did not feel 
pressurized (6.11 ± 0.73) and reported high levels of 
interest and enjoyment (6.00 ± 1.82). They also agreed 
that they had participated voluntarily (6.78 ± 0.55) and 
evaluated their own effort positively (6.11 ± 1.34). The 
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motivation and satisfaction levels were positive, as 
reflected in a mean score on the QUEST scale of 3.81 
out of 5 (SD = 0.38) (see Fig. 6a). On both those scales, 
a higher score means that the participant is more moti-
vated or satisfied (the result of the pressure/tension 
subscale has been normalized).
The results of the AA Questionnaire test are pre-
sented in Table  2. The participants rated the system 
with an average of 6 on a scale of 7, and it can therefore 
be concluded that they considered it easy to learn, easy 
to use and intuitive. They also considered that the sys-
tem affects their treatment positively because it allows 
them to train longer, and they reported that this ther-
apy could be more entertaining compared to the regu-
lar therapy (6 out of 7). All the participants agreed that 
they would recommend the system to other patients, 
but some improvements were proposed. Some exam-
ples of the participants’ proposals can be found in the 
next section (see Open-ended questions).
Open‑ended question
The participants were motivated to participate both dur-
ing the clinical trials and the rehabilitation sessions. At 
the end of the trials, all of them gave positive answers to 
the questions regarding the use of the MERLIN system 
at home. The patients stated that they had enjoyed their 
participation and valued positively this different style of 
therapy for the rehabilitation of their affected arm. Some 
of them stressed the aspects they liked most:
• “It is a new attractive and motivating therapy”.
• “The MERLIN system is an entertaining and easy to 
use therapy, which allows you to repeat an exercise 
many times”.
• “We can decide on the most convenient time for 
doing the therapy”.
Some participants also expressed negative aspects. The 
height and size of the robot did not allow all the patients 
to adopt a completely relaxed posture. Regarding the 
serious games, some participants complained about the 
limited range of games and how simple they were. The 
participants, both patients and clinicians, proposed the 
following future improvements:
• Improve robot design to allow a relaxed arm posi-
tion.
• Adjust the dimensions and reduce the size and the 
area to better suit home use.
• Include more games and make them more attractive.
• Develop more complex games with greater cognitive 
involvement.
Finally, the participants were asked about their willing-
ness to pay for a therapy using the MERLIN system and 
what price they would be willing to pay.  88.9% of the par-
ticipants said they were in favour of paying for a system 
like MERLIN for more than 6 weeks and they would be 
willing to rent it for 40–60 € per month.
Clinical results
Although the aim of these trials was not to measure the 
effectiveness of the system, some measurements of the 
mobility status of the participants were also taken before 
and after the use of MERLIN, with the aim of detecting 
any unforeseen negative effects in the patients. As pre-
viously explained, the Fugl-Meyer and MAS scales were 
used with this aim. The outcome measurements are 
shown in Tables 3 and 4. From the data gathered, it can 
be stated that there was a visible improvement on the 
Fugl-Meyer scale after rehabilitation using the system 
(T1), with significant changes in upper limb and coordi-
nation (p = 0.008 and p = 0.004, respectively), and in the 
total score for motor function (p = 0.002).
Table 1 Demographic information of patients
Gender: M = Male, F = Female; Hemiparesis/Dominant Hand: L = Left, R = Right; Other therapies: Y = Yes, N = No
Age Gender Hemiparesis Dominant Hand Months 
since stroke
Employment situation Other 
therapies
P1 59 M L R 2 Medical leave Y
P2 60 M R R 5 Medical leave Y
P3 70 F L R 6 Retired Y
P4 74 M R R 6 Retired Y
P5 41 M L R 37 Medical leave Y
P6 42 F L R 17 Unemployed Y
P7 89 M L R 4 Retired N
P8 69 F L R 7 Retired Y
P9 71 M R R 35 Retired Y
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However, since there were no significant changes in 
MAS outcomes (p = 0.169), this kind of robot-based ther-
apy does not seem to influence the spasticity of the upper 
limb.
Discussion
The aim of this study was to analyse the user accept-
ance and usability of the MERLIN system in the home 
environment in patients with upper limb motor impair-
ment after a stroke.  In this study, since we also aimed 
to observe the possible changes in the patients’ clinical 
condition after participating in the trials, some additional 
clinical measurements were also added. When new tech-
nology for rehabilitation is developed, the final users’ spe-
cial needs and their mobility limitations must be taken 
into consideration in order to guarantee that the system 
design meets their real needs and requirements [44]. In 
addition, the usability of the system must be evaluated to 
build a system which is comfortable and motivating, and 
which patients are willing to use, in order to ensure bet-
ter adherence to treatment in the future.
Numerous studies over the last few decades have 
shown the effectiveness and the advantages of using 
robotic systems for neurorehabilitation [45–47] and 
tele-rehabilitation in last decades [48–50]. Other stud-
ies have also demonstrated that the use of an exo-
skeleton with a patient-driven control strategy for 
rehabilitation, in which the patient plays an active role 
during the therapy sessions, helps to make the treat-
ment more attractive and therefore more effective 
[51]. In this study, a robotic tele-rehabilitation system 
based on serious games was set up for testing in the 
post-stroke patients’ home. This is the first time that 
this system has been tested in a home environment, as 
it was previously tested in a clinical setting [24, 18, 27].
The positive results for usability obtained in this 
study agree with other home-based studies published 
in recent years [5, 52, 53]. 9 patients completed the 
study and their overall ratings on the different scales 
were positive. The mean obtained for the SUS scale was 
71.94, which is considered as ‘Good’ on the usability 
scale [44] and is higher than other similar studies that 
investigated system usability for similar technology for 
rehabilitation, such as Nijenhuis et al., which was rated 
at 69.0 [54], or Radder et al. with 70.1 [55].
In addition, the mean of 6.06 out of 7 points for IMI, 
with a minimum of 5.67 on each subscale, indicates that 
participants perceived the system as an interesting and 
motivational system to use. The abovementioned stud-
ies also evaluated the system using this scale, obtain-
ing a mean of 5.2 and 5.1 respectively [54, 55], which 
is lower than the results obtained with the MERLIN 
system.
Regarding the results of the QUEST and AA Ques-
tionnaires, the participants perceived this therapy as 
interesting and motivating, as well as simple, intui-
tive and easy to use. However, P4 and P8 expressed a 
slightly more negative view compared to the rest. P4 
was not used to using new technology and felt frus-
trated when interacting with the computer and games. 
P8 has severe motor impairment, which meant much 
more effort was required to move the arm compared 
with the other participants. Despite these drawbacks, 
both patients decided to complete the intervention.
Table 3 Fugl-Meyer Motor function outcomes
T0 = baseline and T1 = post‑training sessions
SD standard deviation, P Participant
a Maximum score for each motor component of the assessment
Upper limb  (36a) Wrist  (10a) Hand  (14a) Coordination  (6a) Motor function  (66a)
T0 T1 T0 T1 T0 T1 T0 T1 T0 T1
P1 31 36 9 9 14 14 5 6 58 63
P2 23 28 7 10 10 11 4 4 44 52
P3 32 36 10 10 13 14 5 6 60 66
P4 30 31 9 9 13 13 4 4 56 57
P5 24 26 3 4 8 8 3 4 38 42
P6 26 30 7 9 14 14 5 6 52 59
P7 32 32 10 10 12 12 4 5 58 59
P8 9 10 3 3 6 7 3 3 21 23
P9 32 32 9 10 12 12 3 4 56 58
MEAN 26.56 29.00 7.44 8.22 11.33 11.67 4.00 4.67 49.22 53.22
SD 7.49 7.84 2.74 2.73 2.78 2.60 0.87 1.12 12.84 13.25
T‑test t = − 3.55; p= 0.008 t = − 2.14; p=0.065 t = − 2.0; p= 0.081 t = − 4.0; p= 0.004 t = − 4.54; p= 0.002
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The open-ended questions about the participants’ 
subjective opinion showed that they enjoyed the ther-
apy using the MERLIN system, which indicates the 
potential for robotic systems based on serious games 
to be used for making people with stroke more actively 
involved in their rehabilitation sessions. In addition, 
the researchers observed and perceived that the use of 
feedback like games’ scores or positive messages and 
the possibility of following up their own evolution, 
motivated them: the patients were very positive about 
this feedback option, which helped them engage better 
with the therapy.
It should be highlighted that the 100% of the partici-
pants would recommend using the MERLIN system to 
other patients, and 88.9% would use it for more than 6 
weeks. All the participants reported low or no levels 
of stress when using MERLIN at home on their own. 
Despite the general positive perception, participants also 
considered that MERLIN would need some improve-
ments, which will be considered when the system is 
developed further. The size and height of the device, as 
well as the inclusion of new games and improvements 
in the design are some examples of proposals for usabil-
ity made by the participants. Although the participants 
recruited in the current evaluation were not cognitively 
affected due to the inclusion criteria, these games were 
designed for all types of post-stroke patients, and so not 
all the software was properly adapted for the participants. 
However, the MERLIN system also offers the option of 
selecting online games, but only if the therapist considers 
that the patient has enough mobility control to play them 
and not get frustrated.  The participants agreed that the 
number of games was limited and some of them became 
too easy after a few sessions of training at home. Despite 
the fact that during the project, the number of the objec-
tives for each game was increased (number of images, 
words, etc. to be achieved), we feel that, considering the 
feedback given and other studies using virtual reality [56, 
57] or collaboration-based games [58, 59] the number of 
Table 4 MAS outcomes at T0–T1
P participant
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Fig. 5 Individual results on SUS Scale (0–100 %)
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games should be extended with the help of health profes-
sionals to engage patients in longer therapies.
As stated above, the aim of this study was to evalu-
ate the usability of the system, and, in that respect, the 
intervention timeline and the number of patients used 
were too small to fully demonstrate the effectiveness of 
the therapy. However, the clinical assessment showed 
moderate improvements in motor function in the upper 
limbs which agrees with results found in other stud-
ies carried out with similar robotic systems in the home 
environment [60, 61]. On an individual level, the nine 
participants were classified for motor function as mildly 
(6 patients), moderately (2) and severely (1) impaired on 
the baseline measurements using Fugl-Meyer scale. The 
participants achieved a notable improvement, which 
was evaluated using the Fugl-Meyer motor function 
scale after training. The intervention involved patients 
in the subacute, short-term chronic and long-term 
chronic phases, according to the inclusion criteria. More 
changes were expected in patients considered subacute 
after training, as theoretically most recovery from spe-
cific impairments occurs during the 6 first months after 
stroke [62, 63]. However no great differences were found 
in their progress. In fact, P6, a patient in the chronic 
phase, experienced the greatest motor change. The most 
significant changes were experienced by P6, P2 and P3: 
these patients were in different phases of evolution and 
had a different baseline, as can be seen in Tables  1 and 
3, respectively. Therefore, in this study, no relationship 
was found between motor function improvements and 
progress, and as most of the participants were also taking 
part in additional therapies, the improvements cannot be 
ascribed exclusively to the use of the MERLIN system.
On the other hand, since there were no significative 
changes to MAS (p = 0.169), it can be concluded that 
the use of this system does not have any influence on 
the upper limb spasticity. This result can be considered 
positive because, in addition to the intrinsic factors that 
cause spasticity, it has been suggested that extrinsic fac-
tors (noxious triggers) may increase the spasticity. These 
factors could include mental stress, physical contact, 
anxiety, pain, muscle fatigue, muscle contractures, cer-
tain body postures, jerky movements or changes of posi-
tion, among others [64], which could induce or aggravate 
high muscle tone and induce pain. None of the patients 
reported an increase in spasticity or a reduction in mobil-
ity after using the system, which demonstrates that MER-
LIN does not cause any noxious triggers.
According to the clinical results, none of the patients 
reported a reduction of the mobility or increased the 
spasticity after using of the system, which demonstrates 
that its use at least safe.
Additionally, there were no serious adverse side effects 
during the study. Mild shoulder pain, mild fatigue and 
chafing of the skin were the only adverse effects noted. 
Therefore, this study provides evidence that the MERLIN 
system may be used safely in a home setting.
Future studies might consider greater using a number 
of participants including a control group, and a longer 
duration of training. Identifying the different patients’ 
factors like age, sex, severity, or evolution of stroke 
could be also helpful with the aim of identifying the tar-
get group. In addition, incorporating additional or more 
complex games and wider range of movements in the 
MERLIN system, would probably enhance motivation, 
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Conclusions
This study demonstrates the usability of the home-based 
MERLIN system in patients with upper limb motor func-
tion impairment after stroke in different stages. The usa-
bility analysis showed that almost 100% of the patients 
who participated found the system useful, safe and 
motivating, and all of them achieved moderate clinical 
improvement in motor function, according to the average 
Fugl-Meyer score.
In this study, the participants carried out 8 additional 
hours of upper limb rehabilitation at home with an inno-
vative approach in neurological rehabilitation, based on 
serious games and using intensive, repetitive, interac-
tive, and individualized practice. The results of this study 
reflect that home training with the MERLIN system with 
the indirect supervision of a therapist could be an inter-
esting approach that includes the most important specific 
features of neurorehabilitation: it is high-intensity, task-
specific, goal-setting, repetitive, functional, meaningful 
and challenging for the patient.
Further research with a larger sample of participants, 
including a control group and a longer intervention, 
would help to explore the efficacy of the system and to 
identify the factors, in order to gather better results on 
neurorehabilitation.
The feasibility of using this low-cost, easy to learn, 
easy to use and easily transportable rehabilitation sys-
tem might constitute a major step forward in transferring 
intensive rehabilitation to the home setting. Nowadays, 
this factor is of special importance due to impact of the 
COVID-19 pandemic.
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